Get access

Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina

Authors

  • Heather D. VanGuilder,

    1. The Penn State Retina Research Group, Ulerich Ophthalmology Research Laboratory, Department of Ophthalmology, Penn State College of Medicine, Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA
    Search for more papers by this author
  • Robert M. Brucklacher,

    1. Department of Functional Genomics Core Facility, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    Search for more papers by this author
  • Kruti Patel,

    1. Department of Functional Genomics Core Facility, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    Search for more papers by this author
  • Rhona W. Ellis,

    1. Department of Cellular and Molecular Physiology, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    Search for more papers by this author
  • Willard M. Freeman,

    1. Department of Functional Genomics Core Facility, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    2. Department of Pharmacology, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    Search for more papers by this author
  • Alistair J. Barber

    1. The Penn State Retina Research Group, Ulerich Ophthalmology Research Laboratory, Department of Ophthalmology, Penn State College of Medicine, Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA
    2. Department of Cellular and Molecular Physiology, Penn State College of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA
    Search for more papers by this author

Dr A. J. Barber, 1Department of Ophthalmology, as above.
E-mail: abarber@psu.edu

Abstract

Diabetic retinopathy can result in vision loss and involves progressive neurovascular degeneration of the retina. This study tested the hypothesis that diabetes decreases the retinal expression of presynaptic proteins involved in synaptic function. The protein and mRNA contents for synapsin I, synaptophysin, vesicle-associated membrane protein 2, synaptosomal-associated protein of 25 kDa and postsynaptic density protein of 95 kDa were measured by immunohistochemistry, immunoblotting and real-time quantitative polymerase chain reaction in whole retinas and retinal synaptosomes from streptozotocin-diabetic and control Sprague–Dawley rats. There was less presynaptic protein immunoreactivity after 1 and 3 months of diabetes than in controls. Discrete synaptophysin-immunoreactive puncta were significantly smaller and fewer in sections from 1- and 3-month diabetic rat retinas than in those from controls. The content of presynaptic proteins was significantly less in whole retinas of 1- and 3-month diabetic rats, and in synaptosomes from 1-month diabetic rats, than in controls. Whole retinas had significantly less mRNA for these genes after 3 months but not 1 month of diabetes, as compared to controls (with the exception of postsynaptic density protein of 95 kDa). In contrast, there was significantly less mRNA for synaptic proteins in synaptosomes of 1-month diabetic rats than in controls, suggesting a localized depletion at synapses. Protein and mRNA for β-actin and neuron-specific enolase were unchanged by diabetes. The ratio of phosphorylated to total synapsin I was also reduced in whole retina and isolated synaptosomes from 1-month diabetic rats, as compared to controls. These data suggest that diabetes has a profound impact on presynaptic protein expression in the retina, and may provide a mechanism for the well-established defects in vision and the electrophysiological response of the retina in diabetes.

Ancillary